Innovations in Childhood Interstitial and Diffuse Lung Disease.

Children's interstitial and diffuse lung diseases (chILDs) are a heterogenous and diverse group of lung disorders presenting during childhood. Infants and children with chILD disorders present with respiratory signs and symptoms as well as diffuse lung imaging abnormalities. ChILD disorders are associated with significant health care resource utilization and high morbidity and mortality. The care of patients with chILD has been improved through multidisciplinary care, multicenter collaboration, and the establishment of patient research networks in the United Stated and abroad. This review details past and current innovations in the diagnosis and clinical care of children with chILD.
Competing Interests: Disclosure Dr A. Casey has no disclosures. Drs E.K. Fiorino and J. Wambach developed continuing medical education in childhood interstitial lung disease for Simumetrix. Support: National Institutes of Health, United States (R01-149853- JAW), Washington University School of Medicine, United States/St. Louis Children’s Hospital Children’s Discovery Institute (JAW).
(Copyright © 2024 Elsevier Inc. All rights reserved.)